FDA Adverse Event Malfunction Summary report: N

ONETOUCHPING GLUCOSEMGMTSYSTEM

MDR report key: 3232416 · Received July 18, 2013

Report

Report Number
2531779-2013-11125
Event Type
Malfunction
Date Received
July 18, 2013
Report Date
June 27, 2013
Manufacturer
ANIMAS CORPORATION
Product Code
LZG
PMA / PMN Number
K080639
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
FL, US
Reporter Occupation
PATIENT

Narratives

Additional Manufacturer Narrative · 1

FOLLOW-UP #1: DATE OF SUBMISSION 10/10/2013-DEVICE EVALUATION: THE INSULIN PUMP HAS BEEN RETURNED AND EVALUATED BY PRODUCT ANALYSIS ON 9/23/2013 WITH THE FOLLOWING FINDINGS: ANIMAS HAS CONDUCTED A REVIEW OF THE DEVICE HISTORY RECORD FOR THIS PUMP AND CONFIRMED THAT IT WAS OPERATING WITHIN REQUIRED SPECIFICATIONS AT THE TIME OF RELEASE. VISUAL INSPECTION OF THE PUMP SHOWED SOME COSMETIC DEFECTS AND THE KEYPAD WAS PEELING. INVESTIGATION REVEALED THAT THE ¿UP¿, ¿DOWN¿ AND ¿OK¿ BUTTONS WERE UNRESPONSIVE WHILE THE CONTRAST BUTTON WAS RESPONDING INTERMITTENTLY. UPON REMOVAL OF THE KEYPAD, CONTAMINATION WAS FOUND UNDER ALL THE BUTTON CONTACTS. UNRELATED TO THIS COMPLAINT, THE DISPLAY SCREEN WAS DIM AND DISCOLORED WHEN PUMP WAS POWER-UP. THE DISPLAY WAS REPLACED WITH A TEST DISPLAY, AND THE TEST SCREEN WAS FUNCTIONING PROPERLY.

Additional Manufacturer Narrative · 1

IF ANIMAS RECEIVES THE PRODUCT ANIMAS WILL INFORM THE FDA OF ANY PRODUCTS THAT FAIL EVALUATION IN A SUPPLEMENTAL REPORT.

Description of Event or Problem · 1

ON (B)(6) 2013, THE REPORTER CONTACTED ANIMAS, ALLEGING A BUTTON/KEYPAD (TACTILE CHANGES/UNRESPONSIVE) ISSUE. THE REPORTER ALLEGED THAT THE KEYPAD BUTTONS WERE INTERMITTENTLY UNRESPONSIVE. THIS COMPLAINT IS BEING REPORTED BECAUSE THE REPORTED ISSUE WAS NOT RESOLVED WITH TROUBLESHOOTING. THERE WAS NO INDICATION THAT THE PRODUCT CAUSED OR CONTRIBUTED TO AN ADVERSE EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
332996 ONETOUCHPING GLUCOSEMGMTSYSTEM INSULIN INFUSION PUMP LZG ANIMAS CORPORATION

Patients

Seq Age Sex Outcome Treatment
1 52 YR